Vivimed Labs Limited — Others, 04-01-2025: Shareholders meeting

Vivimed Labs has shared the voting results from its 36th Annual General Meeting, which confirmed the approval of all resolutions by shareholders. Key outcomes include the adoption of the audited standalone and consolidated financial statements for the fiscal year ending March 31, 2024, the reappointment of Mr. Sandeep Varalwar as a director, and the reappointment of SVRL & Co. as statutory auditors. All resolutions attained a significant majority, indicating strong shareholder support. This positive outcome may enhance investor confidence as it reflects robust governance and shareholder engagement, potentially bolstering the company's strategic initiatives moving forward.